GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (BOM:524372) » Definitions » Buildings And Improvements

Orchid Pharma (BOM:524372) Buildings And Improvements : ₹0 Mil (As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is Orchid Pharma Buildings And Improvements?

Orchid Pharma's annual buildings and improvements increased from Mar. 2023 (₹1,783 Mil) to Mar. 2024 (₹1,859 Mil) but then declined from Mar. 2024 (₹1,859 Mil) to Mar. 2025 (₹0 Mil).

Orchid Pharma Buildings And Improvements Historical Data

The historical data trend for Orchid Pharma's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Buildings And Improvements Chart

Orchid Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,439.38 1,439.38 1,782.58 1,858.79 -

Orchid Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,858.79 - - - -

Orchid Pharma Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Orchid Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (BOM:524372) » Definitions » Buildings And Improvements
Comparable Companies
BOM:509079 BOM:500288 NSE:RPGLIFE BOM:524348 BOM:506879 BOM:512529 BOM:506690 BOM:530239 BOM:524735 NSE:INNOVACAP ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
ORCHPHARMA:India
Address
Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004
Website
http://www.orchidpharma.com
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma Headlines

No Headlines